Maria Isadora Gabriel Sampaio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Isadora Gabriel Sampaio has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Lofrano-Porto
Adrenal and Gonadal Diseases Clinic, Section of Endocrinology and Metabolism of the University Hospital, Graduate Program in Health Sciences, University of Brasilia, UnB, Brasília, Brazil
1 shared publication - Cinthia Gabriel Meireles
Molecular Pharmacology Laboratory, Faculty of Health Sciences University of Brasília Brasília Brazil
1 shared publication - Dâmaris Silveira
University of Brasilia
1 shared publication - Eliete Neves Silva Guerra
Laboratory of Oral Histopathology, Health Sciences Faculty University of Brasilia Brasilia Brazil
1 shared publication - João Victor Dutra Gomes
Pharmacy Department, Health Sciences School, University of Brasília, Brasilia 70910-900, Brazil
1 shared publication - Luiz Alberto Simeoni
University of Brasilia
1 shared publication
Latest Publications
- 23 May 2022
- Published by Wiley in Phytotherapy Research
- Vol. 36 (8) , 3032-3079
Effects of medicinal plants and natural compounds in models of prostate cancer related to sex steroids: A systematic review
Prostate cancer remains a health problem for men. Targeting androgen (AR) and estrogen (ER) receptors improves the outcomes of the disease, and many medicinal plants exert their effects by modulating these pathways. Therefore, a systematic review was conducted to identify medicinal plants and their natural compounds that may modulate the AR and/or ER pathways in cell and animal models. A search was conducted across EMBASE, LILACS, PubMed, Scopus, and Web of Science, with grey literature from Google SCHOLAR and ProQuest. Two authors independently selected eligible studies based on their titles and abstracts, and a third author resolved conflicts. Then, data from the full text of eligible studies were extracted and synthesized. In total, 75 studies were included. Results showed the effects of several different medicinal plants and natural compounds in reduction of AR and/or ER transcription and translation and AR secondary effects: cell growth reduction, induction of apoptosis, and cell cycle arrest. In animal models, tumor size reduction, increase in apoptosis, and downregulation of AR expression in tumors were also observed. No single phytochemical group concentrating molecules with anti‐AR and/or ER activity was identified. Nevertheless, several phytochemical compounds showed potential for future clinical studies in the management of the disease.
- 23 May 2022
- Published by Wiley in Phytotherapy Research
- Vol. 36 (8) , 3032-3079
Effects of medicinal plants and natural compounds in models of prostate cancer related to sex steroids: A systematic review
Prostate cancer remains a health problem for men. Targeting androgen (AR) and estrogen (ER) receptors improves the outcomes of the disease, and many medicinal plants exert their effects by modulating these pathways. Therefore, a systematic review was conducted to identify medicinal plants and their natural compounds that may modulate the AR and/or ER pathways in cell and animal models. A search was conducted across EMBASE, LILACS, PubMed, Scopus, and Web of Science, with grey literature from Google SCHOLAR and ProQuest. Two authors independently selected eligible studies based on their titles and abstracts, and a third author resolved conflicts. Then, data from the full text of eligible studies were extracted and synthesized. In total, 75 studies were included. Results showed the effects of several different medicinal plants and natural compounds in reduction of AR and/or ER transcription and translation and AR secondary effects: cell growth reduction, induction of apoptosis, and cell cycle arrest. In animal models, tumor size reduction, increase in apoptosis, and downregulation of AR expression in tumors were also observed. No single phytochemical group concentrating molecules with anti‐AR and/or ER activity was identified. Nevertheless, several phytochemical compounds showed potential for future clinical studies in the management of the disease.